sprite-preloader
Anzeige
Mehr »
Donnerstag, 15.11.2018 Börsentäglich über 12.000 News von 598 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen
14.09.2018 | 16:46
(3 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

LONDON, Ontario, September 14, 2018 /PRNewswire/ --

Trudell Medical International (TMI) is excited to announce its new High-Altitude Sleep Mask is now approved for sale in Austria, Belgium, France, Germany, Italy, the Netherlands, Spain, Switzerland, and the United Kingdom.

Venturing to high-altitude locations is increasingly common, and more and more people are being exposed to the effects of these hypoxic environments. TMI's High-Altitude Sleep Mask is a new Class I medical device that provides a combination of mild exhalation resistance and CO2 rebreathing. The result is a drug-free method of mitigating the effects of disrupted sleep at high-altitude by reducing high-altitude periodic breathing.¹ An added benefit of the TMI High-Altitude Sleep Mask is that rebreathing improves the heat and humidity of inhaled air in the typical cold, dry environment at altitude.

Equally exciting is that a recent pilot study shows that TMI's High-Altitude Sleep Mask also reduces the severity of high-altitude headaches, the most common symptom of Acute Mountain Sickness (aka altitude sickness).¹

For more information please visit http://www.altimatemask.com

¹Based on unpublished results from a pilot study completed in March 2018

Jason Collins, Director Commercial Development, Trudell Medical International, JCollins@trudellmed.com, +1-519-455-7060 ext 2202


© 2018 PR Newswire